Biofourmis

Care delivered at home is the field of Biofourmis, a healthcare technology company. Its connected platform monitors patients continuously and supports care in the home, and the company says it works with health systems, payers, providers and life science companies. It has merged with CopilotIQ to create what it calls an end-to-end platform for AI-driven in-home care.

A platform that reads more than 120 biomarkers

Its technology takes in more than 120 patient biomarkers, which the company says it uses to build precise insights and prompt early action. Patients are watched through the day rather than at set points, with continuous monitoring combined with episodic readings, information supplied by patients and smart notifications that tell care teams about significant changes. The platform works with more than seventy wearable devices, includes customized patient questionnaires and links clinicians with patients through an integrated communication system.

Care management for healthcare partners

Its virtual care management services for healthcare partners include analytics that the company describes as FDA-cleared, simple dashboards for patients and providers, and value-based services. The company says these help improve access to care and reduce its cost, and that together they cover the care continuum from hospital to home.

Care at home and transitions between settings

Biofourmis offers virtual and in-home support, so that clinical, technical and logistical needs are covered by one partner. It says its teams make sure a solution is understood after it is deployed, not just installed. Its acute care at home programs move patients between levels and locations of care while keeping continuity. The company cites outcomes including a seventy percent reduction in thirty-day readmissions, detection of deterioration up to 21 hours sooner, and cost reductions of up to 38 percent in studies it references.

Partners and recognition

The firm says it partners with more than fifty global health systems and payers, and that it holds licensed operations in several US states. Its recognitions include digital health awards and places in remote patient monitoring rankings, which the company presents as evidence of its standing in the field.

Expanding access to care

The company says its partnerships are meant to expand access to care in local communities, and it presents its platform as a way to deliver care to everyone, everywhere, with the home as a site of care rather than only the hospital.